IDEAYA Biosciences (NASDAQ:IDYA) Price Target Raised to $36.00
IDEAYA Biosciences (NASDAQ:IDYA – Free Report) had its price objective boosted by Royal Bank of Canada from $32.00 to $36.00 in a report published on Tuesday morning, Benzinga reports. The brokerage currently has an outperform rating on the stock. Several other equities analysts have also commented on the stock. SVB Leerink assumed coverage on shares […]
More Stories
Norges Bank Makes New $90.91 Million Investment in Generac Holdings Inc. (NYSE:GNRC)
Norges Bank purchased a new position in Generac Holdings Inc. (NYSE:GNRC – Free Report) in the fourth quarter, according to...
Norges Bank Invests $78.19 Million in Federal Signal Co. (NYSE:FSS)
Norges Bank acquired a new stake in Federal Signal Co. (NYSE:FSS – Free Report) in the fourth quarter, HoldingsChannel.com reports....
Norges Bank Invests $83.53 Million in Janus Henderson Group plc (NYSE:JHG)
Norges Bank purchased a new stake in Janus Henderson Group plc (NYSE:JHG – Free Report) during the 4th quarter, according...
1,221,287 Shares in Ryan Specialty Holdings, Inc. (NYSE:RYAN) Acquired by Norges Bank
Norges Bank acquired a new stake in Ryan Specialty Holdings, Inc. (NYSE:RYAN – Free Report) in the 4th quarter, according...
Blair William & Co. IL Reduces Stock Holdings in HubSpot, Inc. (NYSE:HUBS)
Blair William & Co. IL reduced its stake in shares of HubSpot, Inc. (NYSE:HUBS – Free Report) by 18.0% during...
637,616 Shares in MACOM Technology Solutions Holdings, Inc. (NASDAQ:MTSI) Bought by Norges Bank
Norges Bank purchased a new stake in MACOM Technology Solutions Holdings, Inc. (NASDAQ:MTSI – Free Report) during the 4th quarter,...